Small
cap stocks making big moves on Thursday, April 3, 2014 (as of 12 pm EST)
Response Genetics, Inc. (NASDAQ: RGDX)
shares jumped 23% to $1.47 on volume of more than 7.6 million shares Thursday
as the developer and seller of molecular diagnostic tests that help determine a
patient’s response to cancer therapy said it has signed agreements with six
additional health plans across 10 states, bringing the company’s total national
contracted membership to more than 174 million. With these agreements, Response
Genetics is now in-network with a total of 13 Blue Cross Blue Shield health
plans, which brings the total number of “Blues” subscribers with
direct access to Response Genetics to approximately 23 million.
As well,
shares of BG Medicine, Inc. (NASDAQ: BGMD)
sank 19% to $1.56 on more than 4.3 million shares traded as the company
announced that it would sell 6,452,000 shares of its common stock in an
underwritten public offering at a price of $1.55 per share for net proceeds of
approximately $8.9 million. The company anticipates using these funds for its
operations, including, advancing the commercialization of its cardiovascular
diagnostic tests in the United States and Europe and developing new clinical
claims and indications to expand its product pipeline.
Amyris, Inc. (NASDAQ: AMRS),
meanwhile, said it is entering into a collaborative research and development
agreement with BASF SE, in which Amyris will use its strain engineering technology
to develop a microorganism capable of producing a target molecule identified by
BASF. The companies have agreed not to disclose any details of the agreement.
Amyris stock moved up 10% to $4.42.
Finally,
Tarena International, Inc. (NASDAQ: TEDU)
shares powered 14% higher to $10.23 on its first day of trading Thursday.
Tarena International is a provider of professional education services in China.
